Albemarle Corporation

New York Stock Exchange
Back to all articles
Somewhat Bullish +45

Corient Private Wealth LLC Has $3.59 Million Stock Holdings in ...

AI-generated analysis

📈 Corient Private Wealth LLC increased its Albemarle holdings by 48.9% to 25,361 shares worth $3.59 million in Q4.

📊 Institutional ownership remains high at 92.87%, with other firms like Parallel Advisors and Assetmark also adding positions.

💰 Vertical Research upgraded Albemarle to a 'buy' rating with a $224 price objective on May 26th.

📉 UBS Group raised its price target from $230 to $264 and maintained a 'buy' rating in late May.

⚖️ Rothschild & Co lowered its rating to neutral with a $188 price objective, creating analyst divergence.

🏆 Albemarle reported EPS of $2.95 for the quarter, significantly topping the consensus estimate of $1.24.

📈 Revenue surged 32.7% year-over-year to reach $1.43 billion in the most recent quarter.

💵 The company declared a quarterly dividend of $0.405 per share payable on July 1st.

📉 Stock price context shows ALB trading below its 50-day ($176.64) and 200-day ($169.10) moving averages.

👔 CEO J Kent Masters sold 16,393 shares for $3 million in May but retains a $16 million stake.

Bullish Signals
  • Albemarle reported EPS of $2.95 per share, which significantly beat the consensus estimate of $1.24 by $1.71.
  • Revenue increased 32.7% year-over-year to reach $1.43 billion, exceeding analyst expectations of $1.34 billion.
  • Vertical Research upgraded the stock from 'hold' to 'buy' with a specific price objective of $224.00.
  • UBS Group increased its price target from $230.00 to $264.00 and reaffirmed a 'buy' rating.
  • The company maintains a strong balance sheet with a debt-to-equity ratio of 0.23 and a current ratio of 2.07.
  • A quarterly dividend of $0.405 per share was declared, providing income to shareholders of record on June 12th.
Risk Factors
  • The stock is trading below its technical moving averages, opening at $133.69 versus a 50-day average of $176.64.
  • Rothschild & Co lowered the rating from 'buy' to 'neutral' with a lower price objective of $188.00.
  • CEO J Kent Masters sold over $3 million in shares, representing a 15.78% decrease in his personal ownership.
Full Analysis
Corient Private Wealth LLC significantly increased its stake in Albemarle Corporation (NYSE:ALB) by 48.9% during the fourth quarter, purchasing an additional 8,332 shares to hold a total of 25,361 shares valued at $3.59 million. Several other institutional investors, including Parallel Advisors, Eaton Financial, and BNP Paribas, also modestly increased their positions in the specialty chemicals company during the same period. Analyst sentiment remains mixed but generally positive regarding Albemarle's valuation. Vertical Research upgraded the stock to a 'buy' with a $224 price target, while UBS raised its objective to $264. Conversely, Rothschild & Co lowered its rating to neutral at $188. MarketBeat data indicates an average analyst rating of 'Moderate Buy' with a consensus target price of $202.54. Financially, Albemarle reported strong quarterly results in May, posting $2.95 earnings per share which significantly beat the consensus estimate of $1.24. Revenue reached $1.43 billion, representing a 32.7% year-over-year increase. The company also declared a quarterly dividend of $0.405 per share payable on July 1st for shareholders of record on June 12th. Despite the strong earnings beat, the stock price context shows Albemarle trading below its moving averages, having opened at $133.69 compared to a 50-day average of $176.64 and a 200-day average of $169.10. CEO J Kent Masters sold approximately $3 million in shares in May, though he retains a significant personal stake valued at over $16 million.